logo
Share SHARE
FONT-SIZE Plus   Neg

Valspar Q1 Profit Down, Cuts FY View; Shares Down

Paints and coatings maker Valspar Corp. (VAL), Tuesday reported a slight decline in profit for the first quarter, as revenues dropped due to weaker-than-anticipated international markets. Both earnings and revenues for the quarter fell short of analysts' estimates.

Moving ahead, the company trimmed its full-year earnings expectations, anticipating weak demand in certain international markets to continue. Valspar shares are currently down near nine percent on the New York Stock Exchange.

Chief Executive Gary Hendrickson said, "Although we made substantial progress this quarter on a number of key initiatives, international markets were weaker than anticipated."

The Minneapolis, Minnesota-based company's first-quarter profit inched down to $55.02 million from $55.78 million last year. On a per share basis, earnings improved to $0.60 from $0.58 last year, on lower number of shares outstanding for the quarter.

Last year, the company recorded a one-time restructuring charge of $0.04 per share. The absence of any charges in the latest first-quarter partially helped the company's bottom line.

On average, 13 analysts polled by Thomson Reuters estimated earnings of $0.67 per share for the quarter. Analysts' expectations typically exclude one-time items.

First-quarter revenues dropped to $875.2 million from $885.6 million last year. Analysts estimated revenues of $922.05 million for the quarter.

On a reported basis, gross margin advanced to 33.6 percent from 33.1 percent last year.

Looking forward to full-year 2013, Valspar now expect earnings of $3.60 to $3.80 per share, down from previous estimate of $3.65 and $3.85 per share. The Street currently expect earnings of $3.79 per share for the year.

VAL is currently trading at $61.00, down $5.93 or 8.86%, on a volume of 1.3 million, which is above the three-month average.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The bench to bedside journey of drugs is fraught with challenges. It is estimated that only 5 in 5,000 compounds that enter preclinical testing make it to human testing, and out of those 5, only 1 may pass through all the regulatory hurdles needed to reach pharmacy shelves. Major League Baseball is talking expansion for the first time in a few decades. Owners stand to make a pretty penny from expansion fees and subsequent television rights. The possibility of a more balanced schedule is also enticing. Strong expansion candidates in the U.S. and Canada are ready... The New York Times is teaming up with Google again to give away Google Cardboard, the virtual reality headsets, but this time only to its "most loyal" digital subscribers. The company said that the digital-only subscribers selected for this distribution were chosen based on the duration of their subscriptions.
comments powered by Disqus
Follow RTT